Valley Forge Investment Consultants Inc Adv Humacyte, Inc. Transaction History

Valley Forge Investment Consultants Inc Adv

$290 Million
Q4 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$3.21 - $7.86 $35,310 - $86,460	11,000 New	11,000 $35,000
Q1 2022 May 06, 2022	SELL	$4.65 - $7.4 $51,150 - $81,400	-11,000 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$7.25 - $11.6 $79,750 - $127,600	11,000 New	11,000 $80,000
Q3 2021 Nov 05, 2021	SELL	$9.21 - $16.99 $101,310 - $186,889	-11,000 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$9.21 - $16.99 $101,310 - $186,889	11,000 New	11,000 $128,000

Others Institutions Holding HUMA

# of Institutions

172

Shares Held

41M

Call Options Held

553K

Put Options Held

942K

Black Rock Inc. New York, NY

7.14M
Shares

$25.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.6M
Shares

$19.8 Million
0.0% of portfolio
State Street Corp Boston, MA

4.61M
Shares

$16.3 Million
0.0% of portfolio
Woodline Partners LP San Francisco, CA

2.85M
Shares

$10.1 Million
0.11% of portfolio
Geode Capital Management, LLC Boston, MA

2.14M
Shares

$7.56 Million
0.0% of portfolio

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $365M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley Forge Investment Consultants Inc Adv, based on Form 13F filings with the SEC.

News

Stay updated on Valley Forge Investment Consultants Inc Adv with notifications on news.

Account